| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |